Coverage
Filings
| Filing | Date |
|---|---|
| Board of Directors and Auditors of Krona | 14 Mar 2003 |
| Marianne Dicander Alexandersson appointe | 12 Mar 2003 |
| Orion Pharma taking actions to improve | 10 Mar 2003 |
| Orion discontinues deramciclane studies | 18 Feb 2003 |
| ORION GROUP FINANCIAL STATEMENTS BULLETI | 18 Feb 2003 |
| BOARD OF DIRECTORS OF ORION PROPOSES MER | 18 Feb 2003 |
| ORION CORPORATION SHARE REPURCHASE 29.01 | 29 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 28.01 | 28 Jan 2003 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| ORION CORPORATION SHARE REPURCHASE 27.01 | 27 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 24.01 | 24 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 23.01 | 23 Jan 2003 |
| ORION CORPORATION SHARE REPURCHASE 22.01 | 22 Jan 2003 |